Business / Finance

RSS

Abbott to purchase AP214 hormone analogue from Action Pharma

Abbott and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.

4 May 2012

Addus HomeCare first quarter total revenues increase 16% to $67.9M

Addus HomeCare Corporation, a provider of home-based social and medical services focused primarily on the elderly dual eligible population, announced today its financial results for the three months ended March 31, 2012.

4 May 2012

SXC first quarter revenue increases 56% to $1.7 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month period ended March 31, 2012.

4 May 2012

PDL first quarter total revenues decrease to $77.3 million

PDL BioPharma, Inc. (PDL) today reported financial results for the first quarter ended March 31, 2012.

4 May 2012

Affymetrix to acquire eBioscience

Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.

4 May 2012

Emergent BioSolutions first quarter total revenues increase to $50.3M

Emergent BioSolutions Inc. announced today its financial results for the first quarter ended March 31, 2012.

4 May 2012

DXP acquires Industrial Paramedic Services

DXP Enterprises, Inc. announced today the completion of the acquisition of Industrial Paramedic Services, a leading provider of industrial medical and clinical services to industrial clients operating in remote locations and large facilities in Western Canada.

4 May 2012

Lexicon first quarter revenues decrease 50% to $0.3 million

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2012.

3 May 2012

Pacira secures $27.5 million debt financing facility

Pacira Pharmaceuticals, Inc. today announced that it has secured a $27.5 million debt financing facility through Oxford Finance. Pacira will use the proceeds from this financing to refinance the remaining principal of its outstanding term loan and for general corporate purposes.

3 May 2012

Johnson & Johnson announces acquisition of Bioseal

Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co., Ltd. (Bioseal) a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery.

3 May 2012

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

3 May 2012

STAAR Surgical first quarter total revenue increases 4% to $15.5M

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that sales of its Visian ICL product in the first quarter ended March 30, 2012 increased 25% to $8.6 million.

3 May 2012

XenoPort first quarter revenues increase to $10.4 million

XenoPort, Inc. announced today its financial results for the first quarter ended March 31, 2012. Revenues for the quarter were $10.4 million, compared to $0.4 million for the same period in 2011.

3 May 2012

PharMerica first quarter net income increases to $5.6 million

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today reported its financial results for the first quarter of 2012.

3 May 2012

Ligand first quarter total revenues increase to $5.6 million

Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates.

3 May 2012

AtriCure first quarter revenue increases 11.8% to $17.5 million

AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2012.

3 May 2012

ArthroCare first quarter total revenue increases 5.6% to $92.9 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.

3 May 2012

Arena's first quarter net loss decreases to $29.4 million

Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012, and reviewed recent developments.

2 May 2012

Health Care REIT completes acquisition with Chartwell Seniors Housing REIT

Health Care REIT, Inc. announced today that it has completed the acquisition with Chartwell Seniors Housing REIT of 42 seniors housing and care communities in attractive Canadian markets, which was previously announced on February 15, 2012.

2 May 2012

Kindred Healthcare first quarter consolidated revenues increase 33% to $1.6 billion

Kindred Healthcare, Inc. today announced its operating results for the first quarter ended March 31, 2012. The Company's consolidated financial statements include the operating results of RehabCare Group, Inc. since the closing of the acquisition on June 1, 2011.

2 May 2012